ReviewCurrent pharmaceutical design2022

Development of Peptide-based Metallo-β-lactamase Inhibitors as a New Strategy to Combat Antimicrobial Resistance: A Mini-review.

Qipeng Cheng et al.PubMed ↗Publisher ↗

No numbers read from the abstract.